StonvexLoading…
StonvexStonvexStonvexCore line items from AMKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.84B | $1.68B | $6.71B | $4.82B | $2.83B |
Operating Income | Not available | $100.29M | $467.38M | $282.42M | $123.49M |
Net Income | Not available | $83.35M | $373.89M | $202.13M | $75.55M |
EPS (Diluted) | $0.48 | $0.33 | $1.50 | $0.81 | $0.30 |
Total Assets | Not available | $8.30B | $8.14B | $8.19B | $7.71B |
Total Liabilities | Not available | $3.73B | $3.63B | $3.84B | $3.47B |
Cash & Equivalents | Not available | $1.12B | $1.38B | $1.50B | $1.53B |
Free Cash Flow OCF − CapEx | Not available | $-79.52M | $190.99M | $-21.41M | $56.53M |
Shares Outstanding | Not available | 247.83M | 247.30M | 247.19M | 247.14M |